These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 27283774)

  • 1. Psoriasis - The Life Course Approach.
    Linder MD; Piaserico S; Augustin M; Fortina AB; Cohen AD; Gieler U; Jemec GB; Kimball AB; Peserico A; Sampogna F; Warren RB; de Korte J
    Acta Derm Venereol; 2016 Aug; 96(217):102-8. PubMed ID: 27283774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cumulative life course impairment in psoriasis: patient perception of disease-related impairment throughout the life course.
    Warren RB; Kleyn CE; Gulliver WP
    Br J Dermatol; 2011 May; 164 Suppl 1():1-14. PubMed ID: 21477010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psoriasis: is the impairment to a patient's life cumulative?
    Kimball AB; Gieler U; Linder D; Sampogna F; Warren RB; Augustin M
    J Eur Acad Dermatol Venereol; 2010 Sep; 24(9):989-1004. PubMed ID: 20477920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cumulative life course impairment: evidence for psoriasis.
    Mattei PL; Corey KC; Kimball AB
    Curr Probl Dermatol; 2013; 44():82-90. PubMed ID: 23796812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cumulative life course impairment in patients with dermatological diseases, with a focus on psoriasis.
    Romiti R; Magalhães RF; Duarte GV
    An Bras Dermatol; 2024; 99(2):269-276. PubMed ID: 38135557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two key concepts in the life course approach in medicine: allostatic load and cumulative life course impairment.
    Offidani E; Tomba E; Linder MD
    Curr Probl Dermatol; 2013; 44():17-32. PubMed ID: 23796806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concept of major life-changing decisions in life course research.
    Bhatti ZU; Salek S; Finlay AY
    Curr Probl Dermatol; 2013; 44():52-66. PubMed ID: 23796809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Life course impairment and quality of life over time.
    Sampogna F
    Curr Probl Dermatol; 2013; 44():47-51. PubMed ID: 23796808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cumulative life course impairment in other chronic or recurrent dermatologic diseases.
    Ibler KS; Jemec GB
    Curr Probl Dermatol; 2013; 44():130-6. PubMed ID: 23796817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of the use of the dermatology life quality index as a criterion in clinical guidelines and health technology assessments in psoriasis and chronic hand eczema.
    Basra MK; Chowdhury MM; Smith EV; Freemantle N; Piguet V
    Dermatol Clin; 2012 Apr; 30(2):237-44, viii. PubMed ID: 22284138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life and cost of illness in patients with psoriasis in Malaysia: a multicenter study.
    Tang MM; Chang CC; Chan LC; Heng A
    Int J Dermatol; 2013 Mar; 52(3):314-22. PubMed ID: 23414155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients' narratives.
    Foulkes AC; Warren RB
    Curr Probl Dermatol; 2013; 44():145-57. PubMed ID: 23796819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involving the patient: impact of inflammatory skin disease and patient-focused care.
    Feldman S; Behnam SM; Behnam SE; Koo JY
    J Am Acad Dermatol; 2005 Jul; 53(1 Suppl 1):S78-85. PubMed ID: 15968267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality-of-life issues in psoriasis.
    Mukhtar R; Choi J; Koo JY
    Dermatol Clin; 2004 Oct; 22(4):389-95, viii. PubMed ID: 15450335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cumulative life course impairment: paving the way to an extended life course approach in dermatology.
    Linder D
    Br J Dermatol; 2011 May; 164 Suppl 1():v-vi. PubMed ID: 21477009
    [No Abstract]   [Full Text] [Related]  

  • 16. Quality of life in psoriasis patients.
    Augustin M; Radtke MA
    Expert Rev Pharmacoecon Outcomes Res; 2014 Aug; 14(4):559-68. PubMed ID: 24820452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cumulative life course impairment: identifying patients at risk.
    Augustin M
    Curr Probl Dermatol; 2013; 44():74-81. PubMed ID: 23796811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An educational programme for patients with psoriasis and atopic dermatitis: a prospective randomized controlled trial.
    Bostoen J; Bracke S; De Keyser S; Lambert J
    Br J Dermatol; 2012 Nov; 167(5):1025-31. PubMed ID: 22709422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Educational interventions to improve quality of life in people with chronic inflammatory skin diseases: systematic reviews of clinical effectiveness and cost-effectiveness.
    Pickett K; Loveman E; Kalita N; Frampton GK; Jones J
    Health Technol Assess; 2015 Oct; 19(86):1-176, v-vi. PubMed ID: 26502807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psoriasis: epidemiology, clinical features, and quality of life.
    Langley RG; Krueger GG; Griffiths CE
    Ann Rheum Dis; 2005 Mar; 64 Suppl 2(Suppl 2):ii18-23; discussion ii24-5. PubMed ID: 15708928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.